LB Pharmaceuticals (LBRX) executive compensation, 2026 proxy

Heather Turner, Chief Executive Officer, was paid $11.9M in 2025, up 148% from $4.8M the year before.

Filed
April 23, 2026
Annual meeting
June 3, 2026
Pay year
2025
Named executives
3
CEO total pay
$11.9M+148% vs prior year
CEO 2025 Total Pay
$11,884,985Includes $10.9M in option awards
CEO Salary
$568,750Base salary earned in 2025
CEO Bonus
$321,406Discretionary annual bonus for 2025

How Turner was paid

$11.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary5%Bonus3%Option awards91%All other compensation1%

Named executive officers

ExecutiveTotal
Heather TurnerChief Executive Officer$11,884,985
Gad SofferChief Operating and Business Officer$3,808,637
Anna EramoChief Medical Officer$2,376,939

What changed and why

  • 11884985 total compensation was awarded to CEO Heather Turner in 2025.
  • 10865221 of option awards were granted to CEO Heather Turner in 2025.
  • 625000 is the updated annual base salary for CEO Heather Turner.
  • 3808637 total compensation was awarded to Chief Operating and Business Officer Gad Soffer in 2025.
  • 2376939 total compensation was awarded to Chief Medical Officer Anna Eramo in 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.